Skip to content
10-Q

Quarterly Report

AMERICAN ORIENTAL BIOENGINEERING INC

0001019687-13-002604

← back to feed
Filed
Jul 10, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Jun 10, 2013 36.42M sh
Stock Repurchased Q1 2013 · Mar 31, 2013 $0
Capex Q1 2013 · Mar 31, 2013 $357.99K
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$1.85M
Cash And Equivalents Q1 2013 · Mar 31, 2013 $6.42M
Cash And Equivalents Q1 2013 · Dec 31, 2012 $7.1M
Stockholders Equity Q1 2013 · Mar 31, 2013 $307.72M
Stockholders Equity Q1 2013 · Dec 31, 2012 $327.59M
Current Liabilities Q1 2013 · Mar 31, 2013 $103.43M
Current Liabilities Q1 2013 · Dec 31, 2012 $106.21M
Total Liabilities Q1 2013 · Mar 31, 2013 $116.01M
Total Liabilities Q1 2013 · Dec 31, 2012 $118.72M
Current Assets Q1 2013 · Mar 31, 2013 $74.79M
Current Assets Q1 2013 · Dec 31, 2012 $95.45M
Total Assets Q1 2013 · Mar 31, 2013 $423.73M
Total Assets Q1 2013 · Dec 31, 2012 $446.31M
Sga Expense Q1 2013 · Mar 31, 2013 $12.48M
Rd Expense Q1 2013 · Mar 31, 2013 $1.41M
Net Income Q1 2013 · Mar 31, 2013 −$21.11M
Operating Income Q1 2013 · Mar 31, 2013 −$19.02M
Gross Profit Q1 2013 · Mar 31, 2013 $4.5M
Cost Of Revenue Q1 2013 · Mar 31, 2013 $16.51M
Revenue Q1 2013 · Mar 31, 2013 $21.01M